Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

NCT02152709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1537

Enrollment

NETWORK

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: 3 dose of 10µg/0.5ml hepatitis B vaccine
BIOLOGICAL: 3 dose of 5µg/0.5ml hepatitis B vaccine

Sponsor

Jiangsu Province Centers for Disease Control and Prevention

Collaborators

[object Object]